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Background: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement was 
developed to improve the reporting of observational studies. We aimed to evaluate the quality of reporting in cohort 
studies and case-control studies among observational studies published in the Korean Journal of Family Medicine.
Methods: We searched for cohort studies and case-control studies published as original articles in the Journal of the Korean 
Academy of Family Medicine during the period January 1992 through December 2009. Th   e main outcome measures were the 
number and proportion of cohort studies and case-control studies that reported each of 22 checklist items of STROBE.
Results: We identifi  ed a total of 84 articles, of which 46 articles were cohort studies and 38 were case-control studies. Concerning 
methods, study designs (10%), bias (13%), study size (0%), statistical methods (12-c and 12-e items, 0%; 12-d item, cohort study, 
6%) have been poorly reported. Of results, participants (5-6%), descriptive data (14-b item, 5%), and funding (1%) among other 
information have been poorly reported.
Conclusion: Th   e degree of adherence the STROBE recommendations was relatively low in cohort studies and case-control studies 
published in the Korean Journal of Family Medicine. An eff  ort to improve the reporting of observational studies by application 
and recommendation of the STROBE statement is required.
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processes and outcomes of their studies transparently so that 
the readers can screen out high-quality research and apply it to 
relevant areas. Reporting guidelines are created to help researchers 
present the readers the objectives and design of their studies, 
methods, analysis procedures, results, and the interpretation of 
the results, etc. in their theses.
1) If the contents of research are 
not reported adequately, this makes it diffi   cult for the readers to 
interpret and apply research results eff  ectively.
Accordingly, several institutions established guidelines for 
academic reports by identifying items to be included in research 
by research design. By referring to such guidelines, authors writing 
such reports can keep themselves from omitting important 
information in their reports, and readers, editors and thesis 
reviewers can evaluate the quality of research. Representative 
guidelines recommended for report writing include Consolidated 
INTRODUCTION
A great number of studies are being conducted in 
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Standards of Reporting Trials (CONSORT) for randomized 
controlled trial, Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) for systematic review, 
Meta-analysis of Observational Studies in Epidemiology 
(MOOSE) for the meta-analysis of observational studies, 
Standards for Reporting of Diagnostic Accuracy (STARD) for 
diagnostic accuracy studies, and Strengthening the Reporting 
of Observational Studies in Epidemiology (STROBE) for 
observational studies.
2)
Among them, STROBE is a guideline that was established 
in September 2004 by a number of medical journal editors, 
epidemiological researchers, methodologist, statisticians, and 
clinical researchers for improving the quality of reports from 
observational studies (cohort studies, case-control studies, and 
cross-sectional study).
3) In foreign journals, there is steadily 
increasing evidence that the introduction of CONSORT 
improves the quality of reports from randomized controlled 
trials.
4) In addition, according to the results of evaluating how 
the abstracts of randomized controlled trials and observational 
studies satisfy the guidelines of CONSORT and STROBE, 
abstracts published in 2008 showed a much improved quality 
compared to those in 2005.
5)
Until now there have been two studies on the current state 
and analysis of papers published in the Korean Journal of Family 
Medicine,
6,7) and they showed the steady quantitative growth of 
papers from observational studies. However, no study has been 
conducted on the quality of reports from observational studies, 
which occupy a relatively large portion of papers published in 
the Korean Journal of Family Medicine. Th   us, through this study, 
the authors purposed to assess how the STROBE guidelines are 
satisfi  ed by the theses of cohort studies and case-control studies 
among observational studies published in the Korean Journal of 
Family Medicine and ultimately to contribute to improvement in 
the quality of the Korean Journal of Family Medicine publications.
METHODS
1. Subjects
This study analyzed 1,301 original articles among papers 
published in the Korean Journal of Family Medicine during 
the period from January 1992 (volume 13) to December 
2009 (volume 30), excluding review articles, lectures, special 
contributions, case reports, seminars, training and education, 
summaries of domestic and foreign theses, research topic 
announcements, and posters. Th   e reason for limiting the scope to 
those from volume 13 is that some of the contribution rules were 
changed in 1992.
2. Selection of Subject Theses
In consideration of the scale and effects of research, 
we included only cohort studies and case-control studies 
among observational studies. Two of the authors searched for 
theses separately and checked their titles and abstracts, and if 
information was not enough from the title and the abstract of a 
thesis we determined whether to include the thesis by checking 
its original text. If the two authors did not agree with each other, a 
third author joined the discussion and the three authors decided 
whether to include the thesis. Th  e  defi  nitions of cohort study and 
case-control study followed what is explained in STROBE,
8) and 
deficiencies were supplemented with other literature (National 
Health Service).
9) Reports were classified using the flow chart 
of the classification tool developed by Kim et al.
10) and those 
classified as cohort studies or case-control studies were used as 
the sample of this study.
3. Evaluation of Thesis Quality
For the theses selected as the sample of this study, we 
evaluated whether their reporting observed the methods 
recommended in the STROBE reporting guidelines. The 
evaluation was made by two of the authors. Before evaluation, the 
two authors obtained full understanding of the defi  nition of each 
item in the STROBE checklist
11) and went through a training 
course for evaluating cohort studies and case-control studies. 
When the two authors’ opinions were diff  erent from each other, 
they were adjusted through consultation with a third author.
The STROBE checklist consists of 22 items. Among them, 
18 are common items evaluated regardless of research design, 
and the other 4 items (no. 6, 12, 14, 15) are diff  erent according 
to research design so they are evaluated diff  erently according to 
research design (Appendix 1). Some items (no. 8, 13, 14, 15) are 
applied, respectively, to the exposed group and the non-exposed 
group in cohort studies, and to the patient group and the control 
group in case-control studies. In case an item is divided into  Mi Ra Kim, et al: Quality of Reporting in Korean Journal of Family Medicine
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several sub-items (a)-(e) as in item no. 1, 6, 12, 13, 14, and 16, 
each sub-item was evaluated separately. As a result, a total of 34 
items were evaluated.
In the evaluation of a paper, each item was marked ‘yes’ if the 
item was described well, ‘partially’ if described partially, and ‘no’ if 
described inadequately. For each thesis, we evaluated the degree 
in which the items of the STROBE checklist were reported and, at 
the same time, we counted the number and proportion of theses 
reporting each item ‘yes,’ ‘partially,’ or ‘no.’ Further, we divided 
cohort studies and case-control studies into 10 years’ periods, 
counted the average number of items reported ‘yes’ in each thesis 
for each period, and compared the results in order to examine 
change in reporting patt  erns over time.
RESULTS
1. Quantitative Change in Observational 
Studies over Time
Among theses published in the Korean Journal of Family 
Medicine during the period from 1992 to 2009, 1,301 original 
articles were collected through a search and were classifi  ed based 
on their abstracts and original texts into 46 cohort studies (19 
prospective cohort studies, 27 retrospective cohort studies), 38 
case-control studies, and 942 cross-sectional studies (Figure 1). 
When cohort studies and case-control studies were divided into 5 
years’ periods and the quantity of published theses was compared 
among the periods, steady quantitative growth was observed 
since the period of 1992-1995 (Table 1).
2. Analysis by Item of the STROBE Checklist
Reporting on common items applicable regardless of research 
design was quite varied between 0-95%, and mainly information 
on methods, results and research fund support was inadequate 
(Table 2). Reporting on items applicable only in cohort studies 
was between 6-89%, and especially information on statistical 
methods (12-d) and technical data (14-c) was insuffi   cient (Table 
3). Reporting on items applicable only in case-control studies 
was between 59-92%, relatively satisfactory (Table 4). Among 
the items of the reporting guideline, those evaluated ‘yes’ in over 
80% of the theses were scientific background/reasons in the 
introduction (2), participants (6-a) and data sources/measuring 
(8) in methods, technical data (14-a) and result data (15) in 
results, and key results (18) in discussion. Items evaluated ‘yes’ in 
over 50% of the theses were title and abstract (1-b), participants 
(6-b), variables (7), quantitative variables (11) and statistical 
methods (12-a, 12-b, and 12-d of case-control studies) in 
methods, major results (16) and other analyses (17) in results, 
and limitations (19), interpretation (20) and generalizability 
(21) in discussion. Items evaluated ‘yes’ in under 20% of the 
theses were title and abstract (1-a), objectives in the introduction, 
research design (4), biases (9) and statistical methods (12-d 
of cohort studies) in methods, participants (13) and technical 
data (14-b) in results, and research fund support (22) in other 
information. Items not reported in any of the theses were sample 
size (10) and statistical methods (12-c, 12-e).
3. Change in Reporting over Time (Figure 2)
In cohort studies, the mean number of items evaluated ‘yes’ 
Figure 1. Flow diagram of included studies.
Table 1. The quantitative change of observational studies according 
to the years.
Year
No. of original 
article
No. of cohort 
studies (%)
No. of case-control 
studies (%)
1992-1995   280  3 (1.1)   7 (2.5)
1996-2000   390  7 (1.8) 14 (3.6)
2001-2005   360 24 (6.7) 11 (3.1)
2006-2009   271 12 (4.4)   6 (2.2)
Total 1,301 46 (3.5) 38 (2.9)Mi Ra Kim, et al: Quality of Reporting in Korean Journal of Family Medicine
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Table 2. Reporting of common items of the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement in 
84 articles published in the Korean Journal of Family Medicines.
Item no. Category
Yes Partly No
No. (%)
Title and abstract
  1 (a) 15 (18) 0 69 (82)
(b) 58 (69) 26 (31) 0
Introduction
  2 Background/rationale 72 (86) 12 (14) 0
  3 Objectives 11 (13) 73 (87) 0
Methods
  4 Study design  8 (10) 0 76 (90)
  5 Setting 35 (42) 49 (58) 0
  7 Variables 50 (60) 34 (40) 0
  8* Data sources/measurement 76 (90) 7 (9) 1 (1)
  9 Bias 11 (13) 0 73 (87)
  10 Study size 0 0  84 (100)
  11 Quantitative variables 53 (63) 0 31 (37)
  12 (a) Statistical methods 43 (51) 26 (30) 4 (5)
(b) 54 (64) 0 30 (36)
(c) 0 0  84 (100)
(d) 0 0  84 (100)
Results
  13* (a) Participants 5 (6) 3 (4) 76 (90)
(b) 4 (5) 0 80 (96)
(c)
† 600
  14* (a) Descriptive data 80 (95) 4 (5) 0
(b) 4 (5) 0 80 (96)
  16 (a) Main results 42 (50) 42 (50) 0
(b) 62 (74) 0 22 (26)
(c)
† 200
  17 Other analyses 57 (68) 0 27 (32)
Discussion
  18 Key results 80 (95) 0 4 (5)
  19 Limitations 62 (74) 0 22 (26)
  20 Interpretation 61 (73) 23 (27) 0
  21 Generalizability 52 (62) 0 32 (37)
Other information
  22 Funding 1 (1) 0 83 (99)
*Give such information separately for cases and controls in case-control studies, and, if applicable, for exposed and unexposed groups in 
cohort. 
†As it is just consideration, give the number of articles reported except proportion. Mi Ra Kim, et al: Quality of Reporting in Korean Journal of Family Medicine
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per thesis was 13.7 in 1992-2000 and 14.86 in 2001-2009, so 
it was 1.16 larger in the 2000s than in the 1990s. In case-control 
studies as well, the number was 13 in 1992-2000 and increased 
by 1.94 to 14.94 in 2001-2009.
DISCUSSION
When this study evaluated the reporting quality of cohort 
studies and case-control studies published in the Korean Journal 
of Family Medicine, the level satisfying the STROBE guidelines 
was quite varied among the papers. In particular, the proportion 
of theses evaluated ‘yes’ was low for items research design (4, 
10%), biases (9, 13%) and sample size (10, 0%) in methods, 
missing data (12-c, 0%), loss to follow up (12-d of cohort studies, 
6%) and sensitivity analysis (12-e, 0%) in statistical methods, 
participants (13, 5–6%) and technical data (14-b, 5%) in results, 
and research fund support (22, 1%) in other information.
Researchers should provide clear information on research 
design so that readers can determine the level of evidence for 
the conclusions of their research. According to our study, only 8 
(10%) of the theses studied described research design and only 
15 (18%) mentioned research design in the title or abstract. In a 
study that evaluated the reporting quality of observational studies 
published in foreign dermatological journals during the period 
from 2005 and 2007, the proportion of papers reporting research 
design was 70%, relatively high.
12) Among observational studies 
published in the Korean Journal of Family Medicine during the 
same period, however, only 1 (11%) reported research design in 
the title or the abstract. Because the reliability of conclusions is 
diff  erent depending on the characteristic of research design, the 
key elements of research design should be stated clearly at the 
early stage of research.
8)
On the other hand, researchers should decide the number of 
subjects with suffi   cient statistical power before starting research. 
This is because when research results are not significant, they 
should judge whether there is no significant difference or a 
signifi  cant diff  erence was not detected due to a small sample size. 
Nevertheless, none of the theses examined in this study reported 
Figure 2. The mean number of "yes" response item in cohort 
studies and case-control studies according to the years.
Table 3. Reporting of items applied to cohort study in the 
Strengthening the Reporting of Observational Studies in 
Epidemiology (STROBE) statement (n = 46).
Item no. Category
Yes Partly No
No. (%)
Method
   6-(a) Participants 41 (89) 5 (11) 0
   6-(b)*   2 (67) 1 (33) 0
   12-(d)
† Statistical methods 2 (6) 0 31 (94)
Results
   14-(c) Descriptive data 11 (24) 0  35 (76)
   15 Outcome data 37 (80) 0    9 (20)
*Give such information for matched studies (n = 3). 
†If researcher 
follow up participants according to years, give such information (n 
= 33).
Table 4. Reporting of items applied to case-control study in 
the Strengthening the Reporting of Observational Studies in 
Epidemiology (STROBE) statement (n = 38).
Item no. Category
Yes Partly No
No. (%)
Method
   6-(a) Participants 34 (92) 4 (8) 0
   6-(b)* 15 (68) 7 (32) 0
   12-(d)* Statistical methods 13 (59) 0 9 (41)
Results
   15 Outcome data 34 (89) 0 4 (11)
*Give such information for matched studies (n = 22).Mi Ra Kim, et al: Quality of Reporting in Korean Journal of Family Medicine
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how their sample size had been decided. In a study in 2005 that 
evaluated the reporting quality of randomized controlled trials 
published in domestic medical magazines, only 8.9% of the papers 
calculated the sample size.
13) Th   is suggests that the importance of 
information on sample size is not recognized properly not only 
in observational studies but also in randomized controlled trials 
published in the Korean Journal of Family Medicine. Th  erefore, 
instead of presenting merely the number of participants, the 
authors should state the process of calculating the number of 
subjects clearly for their readers.
As missing data can infl  uence the generalizability of results or 
cause biases,
11) information on missing data should be included 
sufficiently for readers’ understanding. Loss to follow-up and 
drop-out rate are also part of missing data. In the results of our 
study, reporting quality for missing data in statistical methods and 
results was very low (0-5%). Th   is is because most of the theses 
did not state the number of subjects excluded at each stage and 
the reasons for the exclusion, the reasons for loss to follow-up and 
the drop-out rate, and whether to include censored data or not, 
and did not provide information on missing data for each variable 
of interest. As a high drop-out rate may cause selection biases, it 
is necessary to decide how to deal with drop-outs at the planning 
stage. In studies based on medical records, moreover, if data on 
participants and variables of interest are not sufficient or there 
is loss to follow up, it can enhance reporting quality to provide 
detailed information on missing data through additional surveys 
by phone or mail.
In our results, the proportion of theses reporting items related 
to participants (13) was also relatively low at 5-6%. This was 
because the theses described the sampling of participants, data 
sources, inclusion criteria, the number of subjects, etc., but they 
omitt  ed details on the number of potentially valid participants at 
each stage, the number of subjects who had been followed up to 
the end and were included in the fi  nal analysis, and the reasons 
for the exclusion of non-participants. Th   ese types of information 
are very important because they provide grounds for identifying 
selection biases or confounders. Moreover, research results 
are often interpreted inadequately because the results do not 
represent the target population, and for this reason researchers 
should provide detailed information on the participants.
When change in reporting quality over time was examined, 
the number of items evaluated ‘yes’ per thesis was 1.16 higher in 
cohort studies and 1.94 higher in case-control studies during the 
2000s than in those during the 1990s, showing that improvement 
was not so signifi  cant. Th   e Korean Academy of Family Medicine 
added the observance of reporting guidelines to its information 
of authors in July 2008.
2) Th   ere may be a limitation in comparing 
reporting quality between before and after the revision of 
information of authors because the number of cohort studies 
and case-control studies published in 2009 is small. Nevertheless, 
when reporting quality before the revision of contribution rules 
(1992-2008) was compared with that after (2009), the mean 
number of items evaluated ‘yes’ per thesis in the two periods was 
14.3 and 17.5, respectively, for cohort studies and 13.81 and 16, 
respectively, for case-control studies. This shows that reporting 
quality was higher aft  er the revision.
Langan et al.
12) evaluated how much the guidelines of 
STROBE were satisfi  ed by observational studies published in 5 
dermatological journals during the period from January 2005 to 
December 2007. A total of 138 theses were analyzed, and each 
item was rated ‘yes,’ ‘partially,’ ‘no,’ ‘unclear,’ or ‘not applicable.’ 
Items showing high reporting quality (70-99%) were title and 
abstract, introduction, research design, setting, participants (6-
a), variables, data sources/measuring, result data, key results, 
interpretation, and research fund support. However, reporting 
quality was low for biases (31%), sample size (7%), quantitative 
variables (31%) and statistical methods (6-58%) in methods, 
and participants (6-39%), technical data (8-26%), major 
results (4-53%), other analyses (27%), limitations (55%) and 
generalizability (33%) in results. In comparison with our results, 
the level of reporting quality was generally higher even for low-
quality items.
Muller and Egger
14) sampled 60 theses using by searching 
PubMed using keywords ‘sexually transmitted infection’ and 
‘cohort study’ during the period from April 2004 to March 
2008, and evaluated how properly they reported items related to 
methods and results among the reporting guidelines of STROBE. 
The proportion of theses showing high reporting quality was 
varied between 35-93.3% for method items but was between 
40.0-53.3% for result items. Because they evaluated only some 
of method and result items selectively, their results are not 
comparable with ours.
Our study is meaningful in that it is the first attempt to 
evaluate the reporting quality of observational studies published  Mi Ra Kim, et al: Quality of Reporting in Korean Journal of Family Medicine
Vol. 33, No. 2 Mar 2012  |  85 Korean J Fam Med
in the Korean Journal of Family Medicine. Moreover, in the 
current situation that improvement in reporting quality is 
required in response to the increasing volume of observational 
studies, our results are expected to be helpful for qualitative 
improvement if researchers design their studies in consideration 
of the items whose reporting quality was found to be low in this 
study.
Th   is study has a number of limitations. One is that its subjects 
were limited to theses published in a journal. Th   erefore, it is not 
clear whether the conclusions drawn from this study are limited 
to the Korean Journal of Family Medicine or represent problems 
in all domestic medical journals. In addition, further research is 
necessary to determine improvement in the reporting quality of 
studies aft  er the introduction of the STROBE reporting guidelines 
compared to that before. Second, research on observational 
studies require much knowledge about epidemiologic concepts 
or methodologies, and the authors went through a training course 
for evaluation, but some of our evaluation results might have been 
diff  erent if they were reviewed by epidemiologists or statisticians. 
Third, this study classified the theses using a new classification 
tool developed in Korea and there can be disagreement in thesis 
classification between this tool and other classification tools. 
Fourth, the period after the introduction of STROBE was too 
short to evaluate improvement aft  er the guidelines. Accordingly, 
we can fi  nd the value of this research as a base study to determine 
potential for further improvement rather than in evaluating how 
well the guidelines were observed by theses published in the 
Korean Journal of Family Medicine. Fift  h, because STROBE was 
developed mainly in consideration of Western countries with a 
good research environment, it may be somewhat irrelevant to 
the domestic research environment. In case of research funds, for 
example, theses contributed to the Korean Academy of Family 
Medicine might not mention research funds because few of them 
had received fi  nancial support and this might be mistaken for a 
low reporting quality.
In conclusion, among cohort studies and case-control 
studies published in the Korean Journal of Family Medicine, 
the proportion of theses observing the reporting guidelines of 
STROBE was quite varied and, in particular, items related to 
methods and results showed a low reporting quality. Th  is  suggests 
defi  ciency in key elements for readers to determine the reliability 
of research results. Accordingly, researchers need to design 
research with full understanding of the STROBE reporting 
guidelines and full consideration of items whose reporting quality 
is low. Moreover, if medical journal editors and thesis examiners 
introduce, recommend and educate the guidelines of STROBE, 
they will make positive contributions to improvement in the 
reporting quality of observational studies published in the Korean 
Journal of Family Medicine.
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Appendix 1. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement-checklist of items that should 
be addressed in reports of observational studies.
Item no. Recommendation
Title and abstract
1 (a) Indicate the study’s design with a commonly used term in the title or the abstract.
(b) Provide in the abstract an informative and balanced summary of what was done and what was 
found.
Introduction
  Background/rationale 2 Explain the scientiﬁ  c background and rationale for the investigation being reported.
  Objectives 3 State speciﬁ  c objectives, including any prespeciﬁ  ed hypotheses.
Methods
  Study design 4 Present key elements of study design early in the paper.
  Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, 
follow-up, and data collection.
  Participants 6 (a) Cohort study-Give the eligibility criteria, and the sources and methods of selection of participants. 
Describe methods of follow-up.
Case-control study-Give the eligibility criteria, and the sources and methods of case ascertainment 
and control selection. Give the rationale for the choice of cases and controls.
(b) Cohort study-For matched studies, give matching criteria and number of exposed and unexposed.
Case-control study-For matched studies, give matching criteria and the number of controls per 
case.
  Variables 7 Clearly deﬁ  ne all outcomes, exposures, predictors, potential confounders, and effect modiﬁ  ers. 
Give diagnostic criteria, if applicable.
  Data sources/
    measurement
8* For each variable of interest, give sources of data and details of methods of assessment 
(measurement).
Describe comparability of assessment methods if there is more than one group.
  Bias 9 Describe any efforts to address potential sources of bias.
  Study size 10 Explain how the study size was arrived at.
  Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If applicable, describe which 
groupings were chosen, and why.
  Statistical methods 12 (a) Describe all statistical methods, including those used to control for confounding.
(b) Describe any methods used to examine subgroups and interactions.
(c) Explain how missing data were addressed.
(d) Cohort study-If applicable, explain how loss to follow-up was addressed.
Case-control study-If applicable, explain how matching of cases and controls was addressed.
(e) Describe any sensitivity analyses.
Results
  Participants 13* (a) Report the numbers of individuals at each stage of the study-eg., numbers potentially eligible, 
examined for eligibility, conﬁ  rmed eligible, included in the study, completing follow-up, and 
analyzed.
(b) Give reasons for non-participation at each stage.
*Give such information separately for cases and controls in case-control studies, and, if applicable, for exposed and unexposed groups in 
cohort and cross-sectional studies.Mi Ra Kim, et al: Quality of Reporting in Korean Journal of Family Medicine
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Appendix 1. Continued.
Item no. Recommendation
(b) Give reasons for non-participation at each stage.
(c) Consider use of a ﬂ  ow diagram.
  Descriptive data 14* (a) Give characteristics of study participants (eg., demographic, clinical, social) and information on 
exposures and potential confounders.
(b) Indicate the number of participants with missing data for each variable of interest.
(c) Cohort study-Summarize follow-up time (eg., average and total amount).
  Outcome data 15* Cohort study-Report numbers of outcome events or summary measures over time.
Case-control study-Report numbers in each exposure category, or summary measures of 
exposure.
  Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision 
(eg., 95% conﬁ  dence intervals). Make clear which confounders were adjusted for and why they 
were included.
(b) Report category boundaries when continuous variables were categorized.
(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time 
period.
  Other analyses 17 Report other analyses done-eg., analyses of subgroups and interactions, and sensitivity analyses.
Discussion
  Key results 18 Summarise key results with reference to study objectives.
  Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision. 
Discuss both direction and magnitude of any potential bias.
  Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of 
analyses, results from similar studies, and other relevant evidence.
  Generalizability 21 Discuss the generalizability (external validity) of the study results.
Other information
  Funding 22 Give the source of funding and the role of the funders for the present study and, if applicable, for 
the original study on which the present article is based.
*Give such information separately for cases and controls in case-control studies, and, if applicable, for exposed and unexposed groups in 
cohort and cross-sectional studies.